Health Tech Zone did a recent article on our study comparing the value of clinical outcomes as compared to Health Technology Assessments (HTAs). Our study focused on the differences between the two and how they affect reimbursement decisions.
Our recent global analysis of product evaluations for Health Technology Assessments – which are often influential in decision making for approving and/or providing reimbursement for pharmaceuticals and other medical technology – found that the use of patient-reported outcomes (PROs) increased between 2005 and 2011.
Big data is a big buzzword that's being thrown around a lot lately. Our founder and CEO Yin Ho was recently featured in Xconomy, talking about a range of issues including big data and how Context Matters fits into the discussion.
Pharma Voice did a recent article on our study about the increased use of PROs in product evaluations in the healthcare industry, and how they may be providing additional insight as to how regulatory agencies and even manufacturers make decisions.
Check out this fantastic article about Context Matters in Crain's NY, focused on NY-based technology companies that are having a big impact on the healthcare industry.